Tumor heterogeneity in response to therapy and its association with outcome in patients with metastatic colorectal cancer (mCRC)

被引：0
|
作者：
Liu, Junjia [1 ]
Xie, Hao [2 ]
机构：
[1] Albert Einstein Coll Med, Bronx, NY USA
[2] H Lee Moffitt Canc Ctr Res Inst, Tampa, FL USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5255
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Impact of tumor site on bevacizumab (BEV) efficacy in metastatic colorectal cancer (mCRC)
    Wong, Hui-Li
    Field, Kathryn Maree
    Lomax, Anna
    Tacey, Mark
    Shapiro, Jeremy David
    McKendrick, Joseph James
    Zlmet, Allan Solomon
    Yip, Desmond
    Nott, Louise M.
    Jennens, Ross
    Richardson, Gary Edward
    Tie, Jeanne
    Kosmider, Suzanne
    Parente, Phillip
    Lim, Lionel
    Cooray, Prasad
    Tran, Ben
    Desai, Jayesh
    Wong, Rachel
    Gibbs, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [42] Primary tumor location and survival in general population with metastatic colorectal cancer (mCRC)
    Ahmed, Shahid
    Papneja, Neha
    Emara, Mohamed Elsayed
    Alvi, Riaz
    Asif, Tehmina
    Dorie-Anna, Dueck
    Le, Duc
    Zaidi, Adnan
    Haider, Kamal
    Kanthan, Selliah
    Iqbal, Nayyer
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [43] Primary Tumor Location as a Prognostic and Predictive Marker in Metastatic Colorectal Cancer (mCRC)
    Bahl, Ankur
    Talwar, Vineet
    Sirohi, Bhawna
    Mehta, Prashant
    Arya, Devavrat
    Shrivastava, Gunjan
    Dahiya, Akhil
    Pavithran, K.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [44] Primary tumor resection in metastatic colorectal cancer (mCRC): A prospective cohort study
    Wong, Shu Fen
    Field, Kathryn M.
    Kosmider, Suzanne
    Tie, Jeanne
    Wong, Hui-li
    Ben Tran
    Tacey, Mark
    Shapiro, Jeremy
    McKendrick, Joseph
    Gibbs, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] Prognostic impact of primary tumor location in patients with metastatic colorectal cancer (mCRC) at the salvage lines.
    Nagaoka, Tomoyuki
    Wakatsuki, Takeru
    Shinozaki, Eiji
    Nakayama, Izuma
    Suenaga, Mitsukuni
    Fukuda, Naoki
    Osumi, Hiroki
    Matsushima, Tomohiro
    Ichimura, Takashi
    Ogura, Mariko
    Ozaka, Masato
    Takahari, Daisuke
    Chin, Keisho
    Yamaguchi, Kensei
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [46] Heterogeneity of Metabolic Response to Systemic Therapy in Metastatic Breast Cancer Patients
    Huyge, V.
    Garcia, C.
    Alexiou, J.
    Ameye, L.
    Vanderlinden, B.
    Lemort, M.
    Bergmann, P.
    Awada, A.
    Body, J-J
    Flamen, P.
    CLINICAL ONCOLOGY, 2010, 22 (10) : 818 - 827
  • [47] EGFL7 polymorphism to predict tumor response in metastatic colorectal cancer (mCRC) patients (pts) treated with FOLFIRI and bevacizumab (BV)
    Li, Joseph Ethan
    Zhang, Wu
    Loupakis, Fotios
    Yang, Dongyun
    Wakatsuki, Takeru
    Ning, Yan
    Stintzing, Sebastian
    El-Khoueiry, Rita Elie
    Volz, Nico Benjamin
    Marmorino, Federica
    Schirripa, Marta
    Salvatore, Lisa
    Antoniotti, Carlotta
    Cremolini, Chiara
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [48] Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients
    Lavacchi, Daniele
    Gelmini, Stefania
    Calabri, Adele
    Rossi, Gemma
    Simi, Lisa
    Caliman, Enrico
    Mancini, Irene
    Salvianti, Francesca
    Petroni, Giulia
    Guidolin, Alessia
    Scolari, Federico
    Messerini, Luca
    Pillozzi, Serena
    Pinzani, Pamela
    Antonuzzo, Lorenzo
    HELIYON, 2023, 9 (11)
  • [49] Circulating tumor DNA (ctDNA) dynamics and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) undergoing front-line chemotherapy
    Ghidini, M.
    Hahne, J. C.
    Senti, C.
    Tomasello, G.
    Ratti, M.
    Heide, T.
    Garrone, O.
    Cortellini, A.
    Passalacqua, R.
    Valeri, N.
    ANNALS OF ONCOLOGY, 2023, 34 : S1188 - S1188
  • [50] Association of genetic variations in genes implicated in the axis with outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated with cetuximab plus chemotherapy.
    Miyamoto, Yuji
    Stintzing, Sebastian
    Heinemann, Volker
    Zhang, Wu
    Cao, Shu
    Okazaki, Satoshi
    Berger, Martin D.
    Suenaga, Mitsukuni
    Schirripa, Marta
    Soni, Shivani
    Matsusaka, Satoshi
    Ning, Yan
    Yang, Dongyun
    Gopez, Roel
    Melendez, Elizabeth
    Hanna, Diana L.
    Barzi, Afsaneh
    Baba, Hideo
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345